According to the expression status of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), breast cancer is subclassified into three main molecular subtypes, including hormone receptor-positive, HER2-positive, and triple-negative breast cancer (TNBC) [3]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.